Pharma Stocks
-
Analyst Estimates: Here’s What Brokers Think Of Shionogi & Co., Ltd. (TSE:4507) After Its Half-Year Report
Last week saw the newest half-year earnings release from Shionogi & Co., Ltd. (TSE:4507), an important milestone in the company’s…
Read More » -
Will Botanix Pharmaceuticals’ (ASX:BOT) Investor Outreach Reinforce Management Credibility or Raise Fresh Questions?
Botanix Pharmaceuticals recently held a special call to update investors on its quarterly activity report and Sofdra® topical gel launch,…
Read More » -
Assessing Amneal Pharmaceuticals (AMRX) Valuation After Steady Share Price Gains and Growth Initiatives
Amneal Pharmaceuticals (AMRX) shares inched up around 0.4% on Monday, capping a month where the stock climbed more than 4%.…
Read More » -
Assessing Ascendis Pharma (NasdaqGS:ASND) Valuation Following Expanded SKYTROFA Launch for Adult Growth Hormone Deficiency
Ascendis Pharma (NasdaqGS:ASND) just announced that its SKYTROFA (TransCon hGH) is now broadly available in the United States, with expanded…
Read More » -
Assessing Ionis Pharmaceuticals After Positive Clinical Trial News and a 112% Rally in 2025
If you’re standing at the crossroads of whether to jump into Ionis Pharmaceuticals stock, you’re not alone. Investors are weighing…
Read More » -
What Do Analysts Think About Royalty Pharma Plc (RPRX)?
Royalty Pharma Plc (NASDAQ:RPRX) is one of the most profitable biotech stocks to buy. On October 10, Morgan Stanley analyst…
Read More » -
Analysts Expect Breakeven For Evoke Pharma, Inc. (NASDAQ:EVOK) Before Long
Evoke Pharma, Inc. (NASDAQ:EVOK) is possibly approaching a major achievement in its business, so we would like to shine some…
Read More » -
Xenon Pharmaceuticals (XENE): Evaluating Valuation After Bringing on Veteran CFO Tucker Kelly
Xenon Pharmaceuticals (XENE) recently named Tucker Kelly as its new Chief Financial Officer, effective October 15. Kelly’s track record guiding…
Read More » -
Is New Phase 3 Data on Vimseltinib Changing the Investment Case for Ono Pharmaceutical (TSE:4528)?
Ono Pharmaceutical recently presented two-year efficacy and safety data from the MOTION Phase 3 study of vimseltinib in patients with…
Read More » -
Eli Lilly, Merck and Johnson & Johnson gain on strong pharma outlook
Sel Hardy, senior equity research analyst at CFRA, joins BNN Bloomberg to share her Hot Picks in pharma stocks. The…
Read More »